Provider Profile:
Jeffrey Zonder, M.D.

• Amyloidosis
• Leukemia
• Multiple Myeloma
• Non-Hodgkin Lymphoma
• Plasmacytoma

School

• Wayne State University School of Medicine

Residency

• Primary Care Internal Medicine Residency Program, Strong Memorial Hospital, Rochester, NY

Fellowships

• Hematology/Oncology Fellow, Wayne State University, Detroit Medical Center, Detroit, MI, Hematology/Oncology Chief Fellow, Wayne State University, Detroit Medical Center, Detroit, MI

Awards

• 2019, 2021, 2023 Detroit's Top Doctors, Hour Magazine
• 2007 Wayne State University Division of Hematology-Oncology, Hematology Teaching Attending of the Year
• 2005 Teaching Award, Wayne State University School of Medicine

Professional Memberships

• American Society of Hematology
• American Society of Clinical Oncology
• Southwest Oncology Group, Multiple Myeloma and Special Populations Committees

• A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma.Blood. 2011 Dec 19. [Epub ahead of print]Authors: Zonder JA, Mohrbacher AF, Singhal S, van Rhee F, Bensinger WI, Ding H, Fry J, Afar DE, Singhal AK
• Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial.J Clin Oncol. 2011 Nov 10;29(32):4243-9. Epub 2011 Oct 11.Authors: Richardson PG, Wolf J, Jakubowiak A, Zonder J, Lonial S, Irwin D, Densmore J, Krishnan A, Raje N, Bar M, Martin T, Schlossman R, Ghobrial IM, Munshi N, Laubach J, Allerton J, Hideshima T, Colson K, Poradosu E, Gardner L, Sportelli P, Anderson KC.
• Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia. Intern Med J. 2011 Mar;41(3):286-8. doi: 10.1111/j.1445-5994.2011.02426.x.Authors: Tageja N, Giorgadze T, Zonder J.
• Cancer Patient Fracture Evaluation (CAFE) Investigators.Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011 Mar;12(3):225-35. Epub 2011 Feb 16.Authors: Berenson J, Pflugmacher R, Jarzem P, Zonder J, Schechtman K, Tillman JB, Bastian L, Ashraf T, Vrionis F;
• Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a reandomized Southwest Oncology Group trial (S0232). Blood. 2010 Dec 23;116(26):5838-41. Epub 2010 Sep 27.Authors: Zonder JA, Crowlet J, Hussein MA, Bolejack V, Moore DF Sr, Whittenberger BF, Abidi MH, Durie BG, Barlogie B.